{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:24:09Z","timestamp":1778081049870,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1124\/jpet.113.208991","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T05:30:27Z","timestamp":1384925427000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Mucosal Protective Agents Prevent Exacerbation of NSAID-Induced Small Intestinal Lesions Caused by Antisecretory Drugs in Rats"],"prefix":"10.1016","volume":"348","author":[{"given":"Hiroshi","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikuko","family":"Amagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.208991_bib1","first-page":"106","article-title":"Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract","volume":"19","author":"Akagi","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"Suppl 1","key":"10.1124\/jpet.113.208991_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10620-005-2800-9","article-title":"15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications","volume":"50","author":"Arakawa","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.113.208991_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF01536263","article-title":"Misoprostol reduces indomethacin-induced changes in human small intestinal permeability","volume":"34","author":"Bjarnason","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.113.208991_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ajg.2010.436","article-title":"Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial","volume":"106","author":"Cryer","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/jpet.113.208991_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.gie.2008.08.017","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy","volume":"69","author":"Fujimori","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1124\/jpet.113.208991_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1542-3565(04)00619-6","article-title":"Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo","volume":"3","author":"Goldstein","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1124\/jpet.113.208991_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1542-3565(04)00603-2","article-title":"Visible small-intestinal mucosal injury in chronic NSAID users","volume":"3","author":"Graham","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1124\/jpet.113.208991_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2036.2010.04250.x","article-title":"Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection\u2014the results of a multicentre, double-blind, randomized clinical trial (IMPACT study)","volume":"31","author":"Hiraishi","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/jpet.113.208991_bib9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s10620-008-0507-4","article-title":"Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test","volume":"54","author":"Iijima","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.113.208991_bib10","first-page":"1462","article-title":"Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa","volume":"42","author":"Ishihara","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.113.208991_bib11","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s10620-008-0199-9","article-title":"Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats","volume":"53","author":"Kamei","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.113.208991_bib12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1023\/A:1014725024519","article-title":"16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors","volume":"47","author":"Kunikata","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.113.208991_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-230X-13-85","article-title":"Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study","volume":"13","author":"Kuramoto","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1124\/jpet.113.208991_bib14","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.lfs.2004.03.022","article-title":"Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis","volume":"75","author":"Kyoi","year":"2004","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.208991_bib15","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1023\/A:1010687115298","article-title":"Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials","volume":"46","author":"Leandro","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.113.208991_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1358\/dot.2009.45.12.1441075","article-title":"Association of phosphatidylcholine and NSAIDs as a novel strategy to reduce gastrointestinal toxicity","volume":"45","author":"Lichtenberger","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"10.1124\/jpet.113.208991_bib17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","article-title":"A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy","volume":"128","author":"Maiden","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.113.208991_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/00365520701794121","article-title":"Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study","volume":"43","author":"Matsumoto","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1124\/jpet.113.208991_bib19","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1440-1746.2001.02592.x","article-title":"Protective effect of rebamipide on indomethacin-induced intestinal damage in rats","volume":"16","author":"Mizoguchi","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1124\/jpet.113.208991_bib20","first-page":"216","article-title":"Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms","volume":"51","author":"Mizukami","year":"2012","journal-title":"J Clin Biochem Nutr"},{"key":"10.1124\/jpet.113.208991_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/egh.10.25","article-title":"Rebamipide: a gastrointestinal protective drug with pleiotropic activities","volume":"4","author":"Naito","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1124\/jpet.113.208991_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00535-007-2155-4","article-title":"Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study","volume":"43","author":"Niwa","year":"2008","journal-title":"J Gastroenterol"},{"issue":"Suppl 5A","key":"10.1124\/jpet.113.208991_bib23","first-page":"63S","article-title":"Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications","volume":"117","author":"Peura","year":"2004","journal-title":"Am J Med"},{"key":"10.1124\/jpet.113.208991_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/1071576042000209808","article-title":"Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product","volume":"38","author":"Sakurai","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1124\/jpet.113.208991_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2174\/138161210790945922","article-title":"Role of dietary fiber in formation and prevention of small intestinal ulcers induced by nonsteroidal anti-inflammatory drug","volume":"16","author":"Satoh","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.113.208991_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/jpet.112.197475","article-title":"Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility","volume":"343","author":"Satoh","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208991_bib27","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s10620-009-0893-2","article-title":"Soluble dietary fiber protects against nonsteroidal anti-inflammatory drug-induced damage to the small intestine in cats","volume":"55","author":"Satoh","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.113.208991_bib28","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.2008.156596","article-title":"Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats","volume":"58","author":"Satoh","year":"2009","journal-title":"Gut"},{"key":"10.1124\/jpet.113.208991_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/092986712803413980","article-title":"Management of NSAID\/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents","volume":"19","author":"Satoh","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.113.208991_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gtc.2010.08.010","article-title":"Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention","volume":"39","author":"Scarpignato","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1124\/jpet.113.208991_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00535-011-0397-7","article-title":"Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial","volume":"46","author":"Sugano","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1124\/jpet.113.208991_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000064419","article-title":"Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats","volume":"66","author":"Takeuchi","year":"2002","journal-title":"Digestion"},{"key":"10.1124\/jpet.113.208991_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cca.2009.12.026","article-title":"Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage","volume":"411","author":"Takeuchi","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1124\/jpet.113.208991_bib34","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1248\/cpb.33.3775","article-title":"Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propi oni c acid and related compounds","volume":"33","author":"Uchida","year":"1985","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/jpet.113.208991_bib35","first-page":"474","article-title":"Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals","volume":"34","author":"Ueda","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.113.208991_bib36","first-page":"478","article-title":"Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric mucosal damage induced by various necrotizing agents in rats","volume":"34","author":"Ueda","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.113.208991_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-3565(25)10533-8","article-title":"Irsogladine activates gap-junctional intercellular communication through M1 muscarinic acetylcholine receptor","volume":"274","author":"Ueda","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.208991_bib38","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3748\/wjg.v19.i12.1861","article-title":"Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy","volume":"19","author":"Wallace","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1124\/jpet.113.208991_bib39","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1476-5381.2009.00611.x","article-title":"Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)","volume":"159","author":"Wallace","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.208991_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1472-8206.2003.00125.x","article-title":"The therapeutic potential of NO-NSAIDs","volume":"17","author":"Wallace","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.113.208991_bib41","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","article-title":"Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis","volume":"141","author":"Wallace","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.113.208991_bib42","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cgh.2008.06.021","article-title":"Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study","volume":"6","author":"Watanabe","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1124\/jpet.113.208991_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(87)90649-2","article-title":"Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat","volume":"142","author":"Yamasaki","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.208991_bib44","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1742-1241.2006.01147.x","article-title":"Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?","volume":"60","author":"Yeomans","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1124\/jpet.113.208991_bib45","first-page":"287","article-title":"Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1","volume":"61","author":"Yoda","year":"2010","journal-title":"J Physiol Pharmacol"},{"key":"10.1124\/jpet.113.208991_bib46","first-page":"363","article-title":"Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance","volume":"43","author":"Yoshikawa","year":"1993","journal-title":"Arzneimittelforschung"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652427213X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652427213X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.208991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:10:07Z","timestamp":1739995807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652427213X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S002235652427213X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.208991","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal Protective Agents Prevent Exacerbation of NSAID-Induced Small Intestinal Lesions Caused by Antisecretory Drugs in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.208991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}